BioCentury
ARTICLE | Financial News

Theravance planning $250M note deal

January 17, 2013 1:31 AM UTC

Theravance Inc. (NASDAQ:THRX) said it plans to raise $250 million through the sale of convertible subordinated notes due 2023. BofA Merrill Lynch is underwriter. Theravance said it plans to use a port...